<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05033665</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00013646</org_study_id>
    <nct_id>NCT05033665</nct_id>
  </id_info>
  <brief_title>The Impact of Adequate Water Intake on Exercise Performance and Mood in Women and Men</brief_title>
  <acronym>WEXMO</acronym>
  <official_title>The Impact of Adequate Water Intake on Exercise Performance and Mood in Women and Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dehydration is defined as the state of water deficit due to excessive water losses and/or&#xD;
      small water intake. Underhydration is the result of inadequate water intake leading to&#xD;
      activation of water hormonal homeostasis, characterized by elevated vasopressin, lower&#xD;
      urinary output, and concentrated urine without any measurable changes in total body water. It&#xD;
      is well established that dehydration (water deficit) decreases exercise performance and&#xD;
      worsens mood, mainly in women. However, the impact of increased water intake in underhydrated&#xD;
      individuals on their exercise capacity and mood is not known.&#xD;
&#xD;
      The aim of the proposed study is to investigate the impact of increased water intake in&#xD;
      underhydrated individuals on aerobic exercise performance and mood in both women and men.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>2-mile run-time (min)</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2-mile run-time (min)</measure>
    <time_frame>Day 8</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood</measure>
    <time_frame>Pre-trial on day 1</time_frame>
    <description>Profile of Mood States questionnaire (POMS 2®-Adult Short, Multi-Health Systems Inc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood</measure>
    <time_frame>Post-trial on day 1</time_frame>
    <description>Profile of Mood States questionnaire (POMS 2®-Adult Short, Multi-Health Systems Inc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood</measure>
    <time_frame>Pre-trial on day 8</time_frame>
    <description>Profile of Mood States questionnaire (POMS 2®-Adult Short, Multi-Health Systems Inc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mood</measure>
    <time_frame>Post-trial on day 8</time_frame>
    <description>Profile of Mood States questionnaire (POMS 2®-Adult Short, Multi-Health Systems Inc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine osmolality (mmol/kg)</measure>
    <time_frame>4 - 8 PM on day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine osmolality (mmol/kg)</measure>
    <time_frame>4 - 8 PM on day 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine osmolality (mmol/kg)</measure>
    <time_frame>Upon waking (first morning sample) on day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine osmolality (mmol/kg)</measure>
    <time_frame>Upon waking (first morning sample) on day 8</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine specific gravity</measure>
    <time_frame>4 - 8 PM on day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine specific gravity</measure>
    <time_frame>4 - 8 PM on day 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine specific gravity</measure>
    <time_frame>Upon waking (first morning sample) on day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine specific gravity</measure>
    <time_frame>Upon waking (first morning sample) on day 8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urine color</measure>
    <time_frame>4 - 8 PM on day 0</time_frame>
    <description>Armstrong validated 8-color scale. Minimum score: 1. Maximum score: 8. A higher score indicates a worse outcome (e.g., dehydrated).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine color</measure>
    <time_frame>4 - 8 PM on day 7</time_frame>
    <description>Armstrong validated 8-color scale. Minimum score: 1. Maximum score: 8. A higher score indicates a worse outcome (e.g., dehydrated).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine color</measure>
    <time_frame>Upon waking (first morning sample) on day 1</time_frame>
    <description>Armstrong validated 8-color scale. Minimum score: 1. Maximum score: 8. A higher score indicates a worse outcome (e.g., dehydrated).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine color</measure>
    <time_frame>Upon waking (first morning sample) on day 8</time_frame>
    <description>Armstrong validated 8-color scale. Minimum score: 1. Maximum score: 8. A higher score indicates a worse outcome (e.g., dehydrated).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thirst perception</measure>
    <time_frame>4 - 8 PM on day 0</time_frame>
    <description>175 mm visual analog scale. Minimum score: 0 (not thirsty at all). Maximum score: 175 (extremely thirsty). A higher score indicates a worse outcome (e.g., more thirsty).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thirst perception</measure>
    <time_frame>4 - 8 PM on day 7</time_frame>
    <description>175 mm visual analog scale. Minimum score: 0 (not thirsty at all). Maximum score: 175 (extremely thirsty). A higher score indicates a worse outcome (e.g., more thirsty).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thirst perception</measure>
    <time_frame>Upon waking (first morning sample) on day 1</time_frame>
    <description>175 mm visual analog scale. Minimum score: 0 (not thirsty at all). Maximum score: 175 (extremely thirsty). A higher score indicates a worse outcome (e.g., more thirsty).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thirst perception</measure>
    <time_frame>Upon waking (first morning sample) on day 8</time_frame>
    <description>175 mm visual analog scale. Minimum score: 0 (not thirsty at all). Maximum score: 175 (extremely thirsty). A higher score indicates a worse outcome (e.g., more thirsty).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Dehydration</condition>
  <condition>Mood</condition>
  <arm_group>
    <arm_group_label>Euhydrated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Afternoon urine osmolality &lt; 800 mmol/kg or urine specific gravity &lt; 1.020.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Underhydrated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Afternoon urine osmolality ≥ 800 mmol/kg or urine specific gravity ≥ 1.020.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Increase water consumption</intervention_name>
    <description>The underhydrated individuals will be instructed to increase their water intake for one week in order to meet the following two criteria: a) urinate at least 7 times per day and b) have straw-like color urine. A 2-mile run will be completed before and after the 7-day intervention.</description>
    <arm_group_label>Underhydrated</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Maintain adequate water consumption</intervention_name>
    <description>The subjects that are classified as euhydrated will be asked to maintain high water intake for one week to ensure proper hydration. A 2-mile run will be completed before and after the 7-day intervention.</description>
    <arm_group_label>Euhydrated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adults&#xD;
&#xD;
          -  Residence in Arizona&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of diuretics&#xD;
&#xD;
          -  Use of anti-depressive medication&#xD;
&#xD;
          -  Current pregnancy or lactation&#xD;
&#xD;
          -  Current use of injectable insulin&#xD;
&#xD;
          -  Diagnosed with irritable bowel syndrome&#xD;
&#xD;
          -  Do not pass the Physical Activity Readiness Questionnaire for Everyone (PAR-Q)&#xD;
             screening&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stavros Kavouras, PhD</last_name>
    <phone>602-496-2547</phone>
    <email>Stavros.kavouras@asu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Interdisciplinary Science and Technology Building 8</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stavros Kavouras, PhD</last_name>
      <phone>602-496-2547</phone>
      <email>Stavros.kavouras@asu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>September 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dehydration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Benzocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

